Innovis Asset Management’s EyePoint Pharmaceuticals EYPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q3
$152K Hold
19,031
0.06% 143
2023
Q2
$166K Buy
+19,031
New +$166K 0.06% 153